Chemomab Therapeutics Ltd DRC (CMMB) Financials

$2.58

$-0.02 (-0.77%)

As on 11-Sep-2026 16:23EDT

Market cap

$19 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	0.07	0.05	0.07	0.06	0.03
Gross Profit	--	-0.07	-0.05	-0.07	-0.06	-0.03
Operating Expenses	7.96	9.57	14.74	25.46	28.53	12.34
Operating Profit (EBIT)	-7.96	-9.57	-14.74	-25.46	-28.53	-12.38
Other Income	--	--	--	--	--	--
Profit before Tax	-7.60	-9.00	-13.95	-24.22	-28.18	-12.49
Provision for Tax	--	--	--	0.00	-0.53	0.08
Profit after Tax (Net Income)	-7.60	-9.00	-13.95	-24.22	-27.65	-12.49
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-27.65	-12.48

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	8.68	12.33	13.54	17.00	36.22	61.47
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	0.21	0.32	0.09	0.24
Current Liabilities	1.55	1.48	3.22	4.84	6.75	2.65
Total Liabilities	11.79	13.81	16.96	22.15	43.06	64.35

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.28	0.39	0.92	1.25	1.33	1.67
Current Assets	9.96	13.42	16.04	20.90	41.74	62.69
Total Assets	11.79	13.81	16.96	22.15	43.06	64.35
Total Debt*	--	--	0.32	0.39	0.21	0.34
Net Current Assets	8.40	11.95	12.82	16.06	34.99	60.04

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-11.22	-15.46	-23.55	-20.29	-12.38
Cash Flow from Investing Activities	--	5.43	2.31	15.84	19.46	-45.22
Cash from Financing Activities	--	7.21	9.91	3.49	-0.80	61.12
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.02	-1.15	-0.74	-148.87	-190.14	-4.38
Cash EPS ($)	-0.96	-1.14	-0.74	-148.46	-189.74	-4.37
Adjusted Book Value ($)	1.20	1.58	0.72	104.47	249.13	21.57
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.43	-0.82	-144.75	-139.55	-4.34
Free Cash Flow per Share ($)	--	-1.43	-0.82	-144.76	-140.01	-4.43

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-68.68	-89.25	-90.00	-56.28	-34.11
ROE (%)	-72.33	-69.54	-91.34	-91.02	-56.60	-34.56
ROA (%)	-62.44	-58.46	-71.30	-74.28	-51.47	-32.51
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	55.19	35.09	42.11	10.77	-130.56	-12.10
Net Profit Growth (%)	35.72	35.50	42.43	12.39	-121.40	-6.81
EPS Growth (%)	46.01	-0.56	1.00	0.22	-42.40	0.99
Book Value Growth (%)	-35.17	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.43	-2.45	0.00	-0.02	-1.57
Price / Book Value	2.21	1.05	2.52	0.00	0.01	0.32
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.33	-0.27	-1.37	0.76	1.38	3.33
Close Price ($)	1.62	1.65	7.24	2.04	12.80	27.60
High Price ($)	14.80	14.80	10.20	21.40	30.16	675.20
Low Price ($)	1.35	1.60	1.84	1.68	7.00	25.64
Market Cap ($ Cr)	18.91	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	0.02	0.02	0.01	0.01
Short term debt to equity ratio	--	--	0.01	0.00	0.00	0.00
Current Ratio	6.41	9.08	4.98	4.32	6.18	23.66
Quick Ratio	6.41	--	4.98	4.53	--	24.16
Interest Coverage	--	--	--	--	-80.83	-111.42

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	0.01	-3,556.42	-5,667.86	-8,522.39	-10,762.33
Payable days	--	2,893.82	3,940.51	6,023.10	9,559.10	7,670.43
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.